Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors-Reference-Cited by-同舟云学术

Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors

Published:2008-05 Issue:9 Volume:18 Page:2990-2995
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Antonysamy Stephen S.,Aubol Brandon,Blaney Jeff,Browner Michelle F.,Giannetti Anthony M.,Harris Seth F.,Hébert Normand,Hendle Jörg,Hopkins Stephanie,Jefferson Elizabeth,Kissinger Charles,Leveque Vincent,Marciano David,McGee Ethel,Nájera Isabel,Nolan Brian,Tomimoto Masaki,Torres Eduardo,Wright Tobi

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference15 articles.

1. Control of Hepatitis C: A Medicinal Chemistry Perspective

2. Hepatitis C therapeutics: current status and emerging strategies

3. Benzimidazole Derivatives Bearing Substituted Biphenyls as Hepatitis C Virus NS5B RNA-Dependent RNA Polymerase Inhibitors: Structure−Activity Relationship Studies and Identification of a Potent and Highly Selective Inhibitor JTK-109

4. Fragment-Based Drug Discovery

5. Fragment-Based Lead Discovery Using X-ray Crystallography

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-based Design for Medicinal Chemists;The Handbook of Medicinal Chemistry;2023-02-03

2. Fingerprint-based QSAR Model Generation to Identify Structural Determinants of HCV NS5B Inhibition;Journal of Research in Pharmacy;2023

3. The IQA Energy Partition in a Drug Design Setting: A Hepatitis C Virus RNA-Dependent RNA Polymerase (NS5B) Case Study;Pharmaceuticals;2022-10-08

4. Structure‐based pharmacophore modeling, virtual screening approaches to identifying the potent hepatitis C viral protease and polymerase novel inhibitors;Journal of Cellular Biochemistry;2022-06-20

5. Structural Fluctuations of Aromatic Residues in an Apo-Form Reveal Cryptic Binding Sites: Implications for Fragment-Based Drug Design;The Journal of Physical Chemistry B;2020-11-03